)
)
)
Iovance Biotherapeutics
IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies for the treatment of cancer using personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL). Its lead product, Amtagvi, has been approved in the US and Canada for the treatment of second line metastatic melanoma after progression on checkpoint therapies.
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)